The latest closing stock price for Regulus Therapeutics as of May 28, 2025 is 7.93.
An investor who bought $1,000 worth of Regulus Therapeutics stock at the IPO in 2012 would have $-984 today, roughly -1 times their original investment - a -27.34% compound annual growth rate over 13 years.
The all-time high Regulus Therapeutics stock closing price was 2649.60 on November 07, 2014.
The Regulus Therapeutics 52-week high stock price is 8.20, which is 3.4% above the current share price.
The Regulus Therapeutics 52-week low stock price is 0.83, which is 89.5% below the current share price.
The average Regulus Therapeutics stock price for the last 52 weeks is 2.13.
An investor who bought $1,000 worth of Regulus Therapeutics stock at the IPO in 2012 would have $-984 today, roughly -1 times their original investment - a -27.34% compound annual growth rate over 13 years.
The all-time high Regulus Therapeutics stock closing price was 2649.60 on November 07, 2014.
The Regulus Therapeutics 52-week high stock price is 8.20, which is 3.4% above the current share price.
The Regulus Therapeutics 52-week low stock price is 0.83, which is 89.5% below the current share price.
The average Regulus Therapeutics stock price for the last 52 weeks is 2.13.